Cargando…
Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer’s disease
BACKGROUND: The pathologic accumulation and aggregation of tau is a hallmark of tauopathies including Alzheimer’s disease (AD). However, the molecular mechanisms mediating tau aggregation in AD remain elusive. The incidence of AD is increased in patients with type 2 diabetes (T2DM), which is charact...
Autores principales: | Zhang, Guoxin, Meng, Lanxia, Wang, Zhihao, Peng, Qinyu, Chen, Guiqin, Xiong, Jing, Zhang, Zhentao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800231/ https://www.ncbi.nlm.nih.gov/pubmed/35093145 http://dx.doi.org/10.1186/s13024-022-00518-y |
Ejemplares similares
-
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease
por: Zhang, Zhentao, et al.
Publicado: (2014) -
The role of extracellular Tau in the spreading of neurofibrillary pathology
por: Medina, Miguel, et al.
Publicado: (2014) -
Aluminum and Tau in Neurofibrillary Tangles in Familial Alzheimer’s Disease
por: Mold, Matthew John, et al.
Publicado: (2021) -
Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease
por: Raimundo, Ana F., et al.
Publicado: (2020) -
Fluent molecular mixing of Tau isoforms in Alzheimer’s disease neurofibrillary tangles
por: Dregni, Aurelio J., et al.
Publicado: (2022)